Save 10% off your first order | Limited time offer | Create your account now
Loading...

BRAND

Cefazolin CRS

Downloads

COA COO

Select a product

Cefazolin CRS

API

CAS Number

25953-19-9

Molecular Formula

C14 H14 N8 O4 S3

Product format

Neat

Molecular Weight

454.51

Storage

+5°C

Shipping

Room Temperature

API Family

Cefazolin Sodium

Smiles

Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn4cnnn4)C3=O)C(=O)O)s1

Iupac Name

(6R, 7R)-3-[(5-methyl-1, 3 and 4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Downloads

COA COO

Select a product

Available products

Pack Size SKU
Description Expected Delivery Price Quantity
150mg
EPC0682800

1-2 weeks

Product added to your cart

Product Type

Impurity

Our Impurity Characterized Standards portfolio comprises more than 5,000 compounds accompanied by a comprehensive CoA which can be found in 3 product categories that include a set of different analytical techniques for determining Identity and Purity.

API

We have designed a range of primary API standards manufactured according to international regulations that come with the most extensive Certificate of Analysis which includes Identity checks by several techniques.

Excipient

Excipients standards comes with a detailed Certificate of Analysis with Identity, Purity and Assay data. They are also suitable for use with non-compendial analytical methods.

Custom
Synthesis

We offer tailor-made synthesis services of up to gram-quantities of materials for a wide range of pharmaceutical customers. The customer can order a specific molecule that is only synthesized on your request on the scale, with the purity and with the specification or methods you require.

Read more

Custom package size quote

Request pricing and delivery information for critical raw materials in your supply chain, unique large package sizes or bulk quantities that are not available on the website, and any other customization requests

Contact us

Customer attendance service